Vincent Michael Lawton
Director · Addex Therapeutics Ltd.
Individual
- 2026
- Sep 4, 2026
- 1
Filings (90d)
Other insiders active in the same sector
No other insider has filed at Vincent Michael Lawton's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- R01 Fund LP - $45.65M in SDEV purchases and sales in the last 12 months
- Michael John Kazley - $45.65M in SDEV purchases and sales in the last 12 months
- Stephen Hoge - $45.45M in MRNA purchases and sales in the last 12 months
- Neil Kumar - $45.20M in BBIO purchases and sales in the last 12 months
- James C. Foster - $43.26M in CRL purchases and sales in the last 12 months
- Framework Ventures IV L.P. - $42.62M in SDEV purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Vincent Michael Lawton?
Vincent Michael Lawton is a corporate insider, tracked as Director of Addex Therapeutics Ltd. (ADXN). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Vincent Michael Lawton submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
